Camillo Ferrandina

508 total citations · 1 hit paper
5 papers, 295 citations indexed

About

Camillo Ferrandina is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Camillo Ferrandina has authored 5 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Epidemiology, 1 paper in Infectious Diseases and 1 paper in Surgery. Recurrent topics in Camillo Ferrandina's work include Diagnosis and Treatment of Venous Diseases (1 paper), COVID-19 and healthcare impacts (1 paper) and Aortic Disease and Treatment Approaches (1 paper). Camillo Ferrandina is often cited by papers focused on Diagnosis and Treatment of Venous Diseases (1 paper), COVID-19 and healthcare impacts (1 paper) and Aortic Disease and Treatment Approaches (1 paper). Camillo Ferrandina collaborates with scholars based in Italy and United States. Camillo Ferrandina's co-authors include Luisa Cossu, Luca Luzzani, Elena Conti, Matteo Alberto Pegorer, Alessandro Fossati, Raffaello Bellosta, Gabriele Piffaretti, Luca Attisani, Giuseppe Natalini and Ruth L. Bush and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Vascular Surgery and Leukemia.

In The Last Decade

Camillo Ferrandina

5 papers receiving 284 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute limb ischemia in patients with COVID-19 pneumonia

2020 274 citations Raffaello Bellosta, Luca Luzzani et al. Journal of Vascular Surgery profile →

Peers

Countries citing papers authored by Camillo Ferrandina

Since Specialization

Citations

This map shows the geographic impact of Camillo Ferrandina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camillo Ferrandina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camillo Ferrandina more than expected).

Fields of papers citing papers by Camillo Ferrandina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camillo Ferrandina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camillo Ferrandina. The network helps show where Camillo Ferrandina may publish in the future.

Co-authorship network of co-authors of Camillo Ferrandina

This figure shows the co-authorship network connecting the top 25 collaborators of Camillo Ferrandina. A scholar is included among the top collaborators of Camillo Ferrandina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camillo Ferrandina. Camillo Ferrandina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Inferior Mesenteric Artery Revascularization with ChEVAR in High Risk Patient with Bilateral Occlusion of Internal Iliac Arteries, Case Report and Review of Literature 2022 ·Annals of Vascular Surgery ·Luca Attisani, Matteo Alberto Pegorer, Luca Luzzani, Luisa Cossu, Camillo Ferrandina, (unknown), Max V. Wohlauer, Raffaello Bellosta	1
2	Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients 2021 ·SHILAP Revista de lepidopterología ·Carlo Lombardi, Elena Roca, Barbara Bigni, (unknown), Camillo Ferrandina, Alberto Franzin, (unknown), Marcello Cottini, A. D’Alessio, P. Del Poggio, Gian Marco Conte, Alvise Berti	3
3	Acute limb ischemia in patients with COVID-19 pneumonia breakdown → 2020 ·Journal of Vascular Surgery ·Raffaello Bellosta, Luca Luzzani, Giuseppe Natalini, Matteo Alberto Pegorer, Luca Attisani, Luisa Cossu, Camillo Ferrandina, Alessandro Fossati, Elena Conti, Ruth L. Bush, Gabriele Piffaretti	274
4	Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone 1998 ·Leukemia ·Stefano Sacchi, L Gugliotta, Federico Papineschi, A.M. Liberati, Serena Rupoli, (unknown), Marco Ruggeri, Luigi Cavanna, Alessandro Bucalossi, E. Benedetti, Camillo Ferrandina, (unknown), Monica Morselli, Guido Torelli	16
5	ALPHA-INTERFERON IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: CLINICAL RESULTS AND EVALUATION OF ITS BIOLOGICAL EFFECTS ON THE HEMATOPOIETIC NEOPLASTIC CLONE. 1996 ·IRIS UNIMORE (University of Modena and Reggio Emilia) ·Stefano Sacchi, L Gugliotta, Federico Papineschi, A.M. Liberati, (unknown), (unknown), Marco Ruggeri, Luigi Cavanna, Alessandro Bucalossi, Camillo Ferrandina, Marco Morselli, Giuseppe Torelli	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact